Biologics/Immunotherapy News

ANAHEIM, Calif. — Use of oral mucosal immunotherapy in the form of a toothpaste appeared safe and effective for the treatment of adults with peanut allergy, according to results of the placebo-controlled phase 1 OMEGA safety study.

ANAHEIM, Calif. — An additional 12 months of treatment with a skin patch-based approach to immunotherapy for peanut allergy increased the percentage of toddlers able to tolerate peanut, according to results of the EPOPEX study.

Outcomes improved for patients with severe asthma who took mepolizumab regardless of their other comorbidities, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Providers will gather in Anaheim this week under the banner of “Embracing the Evolution of Patient Care” for the American College of Allergy, Asthma & Immunology 2023 Annual Scientific Meeting.

Tezepelumab reduced exacerbations among patients with severe, uncontrolled asthma across all seasons regardless of their specific seasonal and perennial allergies, according to a study published in Annals of Allergy, Asthma & Immunology.

Tezepelumab reduced exacerbations among patients with severe, uncontrolled asthma across all seasons regardless of their specific seasonal and perennial allergies, according to a study published in Annals of Allergy, Asthma & Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in October.

A four-step rush-induction protocol ending with 0.05 mL of the 1:10 v/v concentration was safe for patients at the beginning of aeroallergen therapy, according to a letter published in Annals of Allergy, Asthma & Immunology.

Sublingual immunotherapy was safe and effective in inducing desensitization and remission of peanut allergy in children aged 1 to 4 years, according to a study published in The Journal of Allergy and Clinical Immunology.

Some patients who use omalizumab to treat their chronic urticaria may discontinue its use to reveal disease remission and avoid drug exposure, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.